210 related articles for article (PubMed ID: 15860745)
1. Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes.
Methe H; Kim JO; Kofler S; Nabauer M; Weis M
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1439-45. PubMed ID: 15860745
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells.
Yang SS; Li R; Qu X; Fang W; Quan Z
Cell Immunol; 2012 Sep; 279(1):96-102. PubMed ID: 23103560
[TBL] [Abstract][Full Text] [Related]
3. Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation.
Konat GW; Krasowska-Zoladek A; Kraszpulski M
J Neurosci Res; 2008 Feb; 86(3):603-9. PubMed ID: 17896797
[TBL] [Abstract][Full Text] [Related]
4. [The effects of atorvastatin on C-reactive protein induced Toll-like receptor 4 expression on CD14+ monocyte].
Peng L; Luo YT; Liu JL
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jul; 39(7):664-9. PubMed ID: 22088250
[TBL] [Abstract][Full Text] [Related]
5. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
Nita IM; Serapinas D; Janciauskiene SM
Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.
Niessner A; Steiner S; Speidl WS; Pleiner J; Seidinger D; Maurer G; Goronzy JJ; Weyand CM; Kopp CW; Huber K; Wolzt M; Wojta J
Atherosclerosis; 2006 Dec; 189(2):408-13. PubMed ID: 16443229
[TBL] [Abstract][Full Text] [Related]
8. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
Takahashi Y; Satoh M; Minami Y; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2010 Jul; 119(9):395-405. PubMed ID: 20524934
[TBL] [Abstract][Full Text] [Related]
9. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation.
Li CH; Wang JH; Redmond HP
J Leukoc Biol; 2006 Apr; 79(4):867-75. PubMed ID: 16461741
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients.
Ando M; Shibuya A; Tsuchiya K; Akiba T; Nitta K
Kidney Int; 2006 Jul; 70(2):358-62. PubMed ID: 16738534
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes.
Ishibashi T; Nagata K; Ohkawara H; Sakamoto T; Yokoyama K; Shindo J; Sugimoto K; Sakurada S; Takuwa Y; Teramoto T; Maruyama Y
Biochim Biophys Acta; 2002 Jun; 1590(1-3):123-30. PubMed ID: 12063175
[TBL] [Abstract][Full Text] [Related]
13. CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes.
Estruch M; Bancells C; Beloki L; Sanchez-Quesada JL; Ordóñez-Llanos J; Benitez S
Atherosclerosis; 2013 Aug; 229(2):356-62. PubMed ID: 23880187
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
[TBL] [Abstract][Full Text] [Related]
15. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Immunobiology; 2012 May; 217(5):533-9. PubMed ID: 21899916
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
17. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
Mirlashari MR; Lyberg T
Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
[TBL] [Abstract][Full Text] [Related]
18. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
[TBL] [Abstract][Full Text] [Related]
19. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.
Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
Metabolism; 2010 Dec; 59(12):1775-83. PubMed ID: 20580035
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 6 down-regulates toll-like receptor-4 expression of a monocytic cell line.
Fiset PO; Tulic MK; Skrablin PS; Grover SM; Létuvé S; Mazer BD; Hamid Q
Clin Exp Allergy; 2006 Feb; 36(2):158-65. PubMed ID: 16433852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
